23 companies

CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv Yield
COPN
Cosmo Pharmaceuticals
CHF 65.901.1%8.6%CHF 1.1bCHF 98.37PE16.1xE21.5%2.9%
NOVN
Novartis
CHF 95.585.9%6.4%CHF 191.1bCHF 102.64PE17.9xE7.3%3.4%
BANB
Bachem Holding
CHF 58.45-1.9%0%CHF 4.4bCHF 76.00PE38.6xE17.8%1.4%
ROG
Roche Holding
CHF 286.004.0%22.2%CHF 229.3bCHF 305.60PE21.4xE10.2%3.4%
SANN
Santhera Pharmaceuticals Holding
CHF 17.1212.8%86.5%CHF 214.2mCHF 25.00PE3.4xS-74.4%n/a
TECN
Tecan Group
CHF 236.003.1%-27.3%CHF 3.0bCHF 283.83PE29.9xE13.9%1.3%
SKAN
SKAN Group
CHF 78.90-0.6%3.8%CHF 1.8bCHF 90.67PE55xE17.8%0.4%
XLS
Xlife Sciences
CHF 20.80-13.3%-56.3%CHF 119.4mn/aPE5.6xn/an/a
SDZ
Sandoz Group
CHF 43.641.7%52.6%CHF 19.1bCHF 44.46PS2.1xE30.0%1.0%
BSLN
Basilea Pharmaceutica
CHF 40.703.4%24.8%CHF 493.3mCHF 77.25PS3.3xE14.9%0%
PPGN
PolyPeptide Group
CHF 25.65-4.8%69.0%CHF 846.0mCHF 36.16PS2.8xE64.9%0%
GALD
Galderma Group
CHF 110.700.8%n/aCHF 26.3bCHF 101.28PS6.7xE36.4%n/a
ADXN
Addex Therapeutics
CHF 0.06-4.7%-19.3%CHF 5.9mCHF 0.16PS10xE18.5%n/a
MOLN
Molecular Partners
CHF 4.80-0.9%15.7%CHF 176.9mCHF 9.75PS29.5xE-9.2%n/a
LONN
Lonza Group
CHF 582.00-1.5%35.2%CHF 42.0bCHF 647.48PE66.1xE20.9%0.7%
NWRN
Newron Pharmaceuticals
CHF 9.460.3%25.8%CHF 188.8mCHF 13.71PS28.7xE42.8%n/a
SFZN
Siegfried Holding
CHF 1,028.003.0%22.7%CHF 4.4bCHF 1,167.67PE34.2xE13.0%0.4%
RLF
Relief Therapeutics Holding
CHF 3.75-6.3%121.6%CHF 47.0mn/aPS5.5xn/an/a
KURN
Kuros Biosciences
CHF 22.957.7%341.3%CHF 868.7mn/aPS16.5xn/an/a
SPEX
Spexis
CHF 0.01-77.8%-96.6%CHF 3.9mn/aPS1.1xn/an/a
DESN
Dottikon ES Holding
CHF 219.001.4%-2.2%CHF 3.0bCHF 350.00PE40.1xS16.4%0%
IDIA
Idorsia
CHF 0.70-3.6%-51.5%CHF 132.7mCHF 1.00PS1.8xE17.4%n/a
CURN
Curatis Holding
CHF 13.00-0.4%n/aCHF 63.1mCHF 20.00n/an/an/a
Page 1 of 1